Research programme: s-salmeterol - Sepracor

Drug Profile

Research programme: s-salmeterol - Sepracor

Alternative Names: (S)-salmeterol; S-salmeterol

Latest Information Update: 11 Jul 2007

Price : $50

At a glance

  • Originator Sepracor
  • Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Small molecules
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 18 Apr 2001 New profile
  • 31 Dec 1999 Preclinical development for Asthma in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top